Skip to main content
CING
NASDAQ Life Sciences

Cingulate Inc. Converts $1.65M Debt to Equity, Issuing Over 426K Shares

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
8
Price
$4.38
Mkt Cap
$29.596M
52W Low
$3.2
52W High
$6.01
Market data snapshot near publication time

Summary

Cingulate Inc. issued common stock valued at approximately $1.65 million to lenders in multiple transactions, converting a portion of its debt into equity and resulting in significant shareholder dilution.


Key Events

  • Debt-to-Equity Conversion

    Cingulate Inc. converted approximately $1.65 million in debt into common stock through a series of unregistered sales to lenders between November 21, 2025, and January 2, 2026.

  • Significant Share Dilution

    A total of 426,853 shares of common stock were issued across six separate transactions, leading to a notable increase in the company's outstanding share count.

  • Balance Sheet Management

    The conversions, exempt under Section 3(a)(9) of the Securities Act, indicate the company's strategy to reduce its debt obligations, which can be a critical step for small-cap companies managing financial health.


Analysis

Cingulate Inc. has engaged in a series of unregistered equity sales, converting approximately $1.65 million of debt into common stock. While this action reduces the company's outstanding debt, it results in significant dilution for existing shareholders, as over 426,000 new shares were issued. For a company of Cingulate's size, such a substantial conversion indicates a need to manage its balance sheet and potentially conserve cash, but at the cost of increasing the share count.

At the time of this filing, CING was trading at $4.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.6M. The 52-week trading range was $3.20 to $6.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CING - Latest Insights

CING
Jun 02, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.79
Real-time Price: $5.08 info
Change: +$1.29 (+34%) info
Market Cap: $65.729M info
CING
Jun 02, 2026, 8:05 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $3.79
Real-time Price: $5.08 info
Change: +$1.29 (+34%) info
Market Cap: $65.729M info
CING
May 29, 2026, 9:16 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $4.30
Real-time Price: $5.08 info
Change: +$0.780 (+18%) info
Market Cap: $65.729M info
CING
May 29, 2026, 8:05 AM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $4.34
Real-time Price: $5.08 info
Change: +$0.740 (+17%) info
Market Cap: $65.729M info
CING
May 19, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.47
Real-time Price: $5.08 info
Change: +$0.608 (+14%) info
Market Cap: $65.729M info
CING
May 19, 2026, 10:13 AM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $4.39
Real-time Price: $5.08 info
Change: +$0.690 (+16%) info
Market Cap: $65.729M info
CING
May 14, 2026, 8:15 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.92
Real-time Price: $5.08 info
Change: +$0.160 (+3%) info
Market Cap: $65.729M info
CING
May 14, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.92
Real-time Price: $5.08 info
Change: +$0.160 (+3%) info
Market Cap: $65.729M info
CING
May 14, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.92
Real-time Price: $5.08 info
Change: +$0.160 (+3%) info
Market Cap: $65.729M info
CING
Apr 28, 2026, 4:24 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $4.84
Real-time Price: $5.08 info
Change: +$0.240 (+5%) info
Market Cap: $65.729M info